by Erin | Sep 19, 2024 | Blog
Following years of fits and starts for Prescription Drug Affordability Board (PDAB) operations, advocates might be surprised to find that two states now seem to be in a race to implement processes for setting upper payment limits. In early September, PDABs met in both...
by Erin | Aug 16, 2024 | Blog
On Friday, August 9, the Maryland Prescription Drug Affordability Board released its draft Upper Payment Limit Action Plan. If the Maryland Prescription Drug Affordability Board determines that a drug “has led or will lead to affordability challenges for the State...
by Erin | Jul 31, 2024 | Blog
Health care payers are intensely focused on the cost of healthcare, particularly pharmaceutical costs. States, as large purchasers of health care, are seeking new and expanded ways to reduce these costs. One means they have recently begun to employ is prescription...
by Erin | Feb 28, 2024 | Papers
Lawmakers say that making medications more affordable to patients is a top priority. Yet some policy approaches overlook what matters most to patients and providers—and even make it more difficult for patients to access the treatment they need. One such approach is...
